Clinical Director, Haemato-oncology Diagnostic Service (HODS) Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories, United Kingdom
BIOGRAPHY
This talk will highlight key changes to the various guidelines in myeloid and lymphoid testing, commenting on the current and future landscape of biomarkers. The speakers will then share the developments they have made in the laboratory and how they are applying these guidelines in their molecular service delivery.